Lung cancer tumor cells in mice communicate with the brain, sending signals to deactivate the body’s immune response, a study ...

Indian researchers reveal how immune cells 'betray' the body, aiding breast cancer spread and suggesting new treatment ...

By Dr. Priyom Bose, Ph.D. By replacing both breathing and circulatory buffering, a novel artificial lung bought critical time after lung removal, revealed irreversible damage, and made transplantation ...

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

New therapy reprograms immune cells inside tumors to attack cancer, bypassing traditional cell therapy manufacturing ...

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...

SNY's phase III LEAP2MONO study meets all primary endpoints, with venglustat improving neurological symptoms in type 3 ...

Invisible particles in the air are not just irritating our lungs, they are quietly rewiring the immune system that is ...

Pittet lab A human head-and-neck tumor containing infiltrating neutrophils. Tumor cells appear in light grey. Among the ...

Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease In the LEAP2MONO phase 3 study, venglustat, dosed orally once daily, demonstrated clinically meaningful ...

Sanofi’s LEAP2MONO phase 3 study of venglustat to treat type 3 Gaucher disease meets all primary endpoints: Paris Tuesday, February 3, 2026, 13:00 Hrs [IST] Positive results fro ...

Researchers at MIT and Stanford University have developed a new way to stimulate the immune system to attack tumor cells, using a strategy that could make cancer immunotherapy work for many ...